Jeanmarie Mayer,
MD
Languages Spoken: English
Jeanmarie Mayer, MD, is the Hospital Epidemiologist for the University of Utah Health Care Hospitals and Clinics. As a Healthcare Epidemiologist and an Infectious Disease specialist, her clinical interests focus on the prevention of healthcare-associated infections. She deals with all aspects of the healthcare setting to reduce the transmission of multidrug resistant organisms and prevent patients or staff from acquiring a healthcare-associated infection through surveillance, conducting outbreak investigations, development of policies, audits, teaching, providing advice and consultation, and leading quality improvement initiatives.
Dr. Mayer received her Bachelor of Science Degree from William Smith College. She received training in medicine from the University of Rochester School of Medicine and Dentistry. In the past, Dr. Mayer served as Chair of the Utah Healthcare Associated Infection Work Group and she currently has a state leadership role as Chair of the Utah Healthcare Infection Prevention Governance Committee. She is a member of the Society for Healthcare Epidemiology of America, and serves on this organization's Guidelines Writing Committee as well as their Expert Antimicrobial Utilization Consultation Panel.
Clinical Locations
801-581-2121
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Epidemiology |
| Board Certification | American Board of Internal Medicine (Internal Medicine) |
Jeanmarie Mayer, MD, is the Hospital Epidemiologist for the University of Utah Health Care Hospitals and Clinics. As a Healthcare Epidemiologist and an Infectious Disease specialist, her clinical interests focus on the prevention of healthcare-associated infections. She deals with all aspects of the healthcare setting to reduce the transmission of multidrug resistant organisms and prevent patients or staff from acquiring a healthcare-associated infection through surveillance, conducting outbreak investigations, development of policies, audits, teaching, providing advice and consultation, and leading quality improvement initiatives.
Dr. Mayer received her Bachelor of Science Degree from William Smith College. She received training in medicine from the University of Rochester School of Medicine and Dentistry. In the past, Dr. Mayer served as Chair of the Utah Healthcare Associated Infection Work Group and she currently has a state leadership role as Chair of the Utah Healthcare Infection Prevention Governance Committee. She is a member of the Society for Healthcare Epidemiology of America, and serves on this organization's Guidelines Writing Committee as well as their Expert Antimicrobial Utilization Consultation Panel.
Academic Locations
School of Medicine
801-585-6667
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Epidemiology |
| Board Certification | American Board of Internal Medicine (Internal Medicine) |
Education History
| Fellowship | University of Utah School of Medicine Pathology Fellow |
| Fellowship | University of Utah School of Medicine Infectious Disease Fellow |
| Research Fellow | Hartford Hospital, Division of Infectious Diseases Infectious Disease Research Fellow |
| Residency | Hartford Hospital Internal Medicine Resident |
| Internship | Hartford Hospital Internal Medicine Intern |
| Professional Medical | University of Rochester Medicine M.D. |
| Undergraduate | William Smith College B.S. |
Selected Publications - Journal Articles
Journal Article
- Bearman G, Bryant K, Leekha S, Mayer J, Munoz-Price LS, Murthy R, Palmore T, Rupp ME, White J (2014). Healthcare personnel attire in non-operating-room settings. Infect Control Hosp Epidemiol, 35(2), 107-21.
- Donskey CJ, Sunkesula VC, Jencson AL, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco S, Sambol S, Petrella L, Terry D, Gerding DN (2014). Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers. J Clin Microbiol, 52(1), 315-8.
- Donskey CJ, Sunkesula VC, Jencson AL, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco S, Sambol S, Petrella L, Terry D, Gerding DN (2013). Utility of a Commercial Polymerase Chain Reaction Assay and a Clinical Prediction Rule for Detection of Asymptomatic Carriers of Toxigenic Clostridium difficile. J Clin Microbiol.
- de Perio MA, Brueck SE, Mueller CA, Milne CK, Rubin MA, Gundlapalli AV, Mayer J (2012). Evaluation of 2009 pandemic influenza A (H1N1) exposures and illness among physicians in training. Am J Infect Control, 40(7), 617-21.
- Mayer J, Greene T, Howell J, Ying J, Rubin MA, Trick WE, Samore MH (2012). Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis, 55(3), 364-70.